TP53 and neoplasm: Serial analyses of cfDNA performed every 2-3 months from D148 to D632 show that overall mutant allele frequencies (MAFs) of BRAF, TP53, and SMAD directly correlate with levels of the serum tumor marker CA19-9 and radiographic results (Figs 1 and 3).